Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean subjects

Benzer Materyaller

• Pharmacokinetics of TKM-130803 in Ebola virus disease in Sierra Leonean patients
  Yazar:: Scott, JT, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: Plasma concentrations exceed target levels, with drug accumulation in the most severe patients
  Yazar:: Scott, JT, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease:  plasma concentrations exceed target levels, with drug accumulation in the most severe patients
  Yazar:: Janet T. Scott, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-02-01)
• Experimental treatment of Ebola virus disease with TKM-130803: A single-arm phase 2 clinical trial.
  Yazar:: Dunning, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial
  Yazar:: Dunning, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)